AstraZeneca, Tempus AI and Pathos AI have entered a multi-year, strategic collaboration to build a multimodal foundation model in oncology.  The model will be used to gather biological and clinical insights, discover novel drug targets, and develop therapeutics for the broader oncology community.  Upon completion, the model will be shared among all three parties to […]